Visura TechnologiesVisura’s single-use TEE Camera Assist Device (TEECAD) attaches to a TEE ultrasound probe for real-time visualization during intubation so the physician can view the esophagus while placing the echo probe.
“TEECAD adds minimally to the profile of the probe, does not interfere with the echocardiogram image capture, requires no modifications to existing ultrasound equipment, and will require minimal physician and staff training,” the company said.
The FDA cleared the device in 2018. This year, the medical device startup hired medtech veteran Christine Horton as president and CEO and launched the device at the American Society of Echocardiography’s Annual Scientific Sessions in June.
Visura says it’s the first and only camera system of its kind on the market, making transesophageal echocardiograms safer for patients and less expensive for hospitals. Complications from the procedure include esophageal or pharyngeal perforation. Visura said a single major complication can cost up to $102,000 per incident.